This inventor holds 1 USPTO granted patent. Top assignee: Evotec Ag. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: James Madden - Innovator in Pharmaceutical Chemistry
Introduction
James Madden is a notable inventor based in Workingham, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as Bradykinin B1 antagonists. His work is essential in advancing medical treatments and improving patient outcomes.
Latest Patents
James Madden holds 1 patent related to his invention of Bradykinin B1 antagonists. The patent describes compounds of formula (I), where R, R, R, R, R, and X, X, X, X have specific meanings as cited in the description and claims. These compounds are valuable as Bradykinin B1 antagonists, and the invention also encompasses pharmaceutical compositions, the preparation of such compounds, and their use as medicaments.
Career Highlights
James Madden is currently employed at Evotec AG, a leading company in drug discovery and development. His role at Evotec AG allows him to collaborate with other experts in the field and contribute to innovative solutions in healthcare.
Collaborations
Some of his notable coworkers include David James Hallett and Alastair L Parkes. Their collaboration fosters a dynamic environment for research and development, enhancing the potential for groundbreaking discoveries.
Conclusion
James Madden's work in pharmaceutical chemistry, particularly with Bradykinin B1 antagonists, showcases his commitment to innovation in medicine. His contributions are vital for the advancement of therapeutic options available to patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile